D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 59 Citations 11,286 162 World Ranking 8410 National Ranking 633

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Biochemistry

Terry D. Butters mostly deals with Biochemistry, Substrate reduction therapy, Glycosphingolipid, Immunology and Enzyme. His research on Biochemistry frequently links to adjacent areas such as Stereochemistry. His biological study spans a wide range of topics, including Glucocerebrosidase, GM2 gangliosidoses, Gangliosidosis and Miglustat.

He has researched Glycosphingolipid in several fields, including Chromatography, Pharmacology, In vivo and Cell biology. His study looks at the relationship between Immunology and fields such as Sandhoff disease, as well as how they intersect with chemical problems. His study in Enzyme is interdisciplinary in nature, drawing from both High-performance liquid chromatography, Glycobiology, Anthranilic acid, Digestion and Monosaccharide.

His most cited work include:

  • Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis (640 citations)
  • N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. (404 citations)
  • Targeting glycosylation as a therapeutic approach (343 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Biochemistry, Stereochemistry, Enzyme, Glycosphingolipid and Glycosylation. His Biochemistry study is mostly concerned with Endoplasmic reticulum, Glycan, Glycolipid, Ceramide and Oligosaccharide. His Stereochemistry study combines topics in areas such as Iminosugar, Biosynthesis, Alkyl and Glycoside hydrolase.

His Glycosphingolipid research is multidisciplinary, incorporating perspectives in Immunology, Miglustat, Ganglioside, Cell biology and Substrate reduction therapy. His studies in Ganglioside integrate themes in fields like HEXB, Sandhoff disease, Endocrinology and Internal medicine. His Glycosylation research includes elements of Mannose and Glycoprotein.

He most often published in these fields:

  • Biochemistry (42.86%)
  • Stereochemistry (28.57%)
  • Enzyme (12.86%)

What were the highlights of his more recent work (between 2011-2020)?

  • Biochemistry (42.86%)
  • Stereochemistry (28.57%)
  • Iminosugar (8.57%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Biochemistry, Stereochemistry, Iminosugar, Glycoprotein and Glycan. His Biochemistry study frequently draws connections between related disciplines such as Miglustat. His research in Stereochemistry intersects with topics in Mannosidase, Glycoside hydrolase and Enzyme.

His Iminosugar research is multidisciplinary, incorporating elements of Cystic fibrosis, Dengue virus, Dengue fever, Alkyl and In vivo. His Glycoprotein research integrates issues from Golgi apparatus, Ubiquitin and Glycosylation. The various areas that he examines in his Glycan study include In vitro and Endoplasmic reticulum.

Between 2011 and 2020, his most popular works were:

  • An iminosugar with potent inhibition of dengue virus infection in vivo. (65 citations)
  • Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses (62 citations)
  • Structural and mechanistic insight into N-glycan processing by endo-α-mannosidase (58 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Organic chemistry

His primary areas of investigation include Stereochemistry, Biochemistry, Iminosugar, Enzyme and Enantiomer. Terry D. Butters combines subjects such as Mannosidase, Miglitol, Cleavage and Disaccharidase with his study of Stereochemistry. His studies in Protein folding, Cystic fibrosis transmembrane conductance regulator, Glucosidases, RNA and Secretion are all subfields of Biochemistry research.

His work deals with themes such as Prodrug, Enzyme assay, Acetylation and Alkyl, which intersect with Iminosugar. Terry D. Butters interconnects Cell culture, Fibroblast and Molecular biology in the investigation of issues within Enzyme. His studies deal with areas such as Miglustat, Maltase, Hydroxymethyl and Maltose as well as Enantiomer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis

T Cox;R Lachmann;C Hollak;J Aerts.
The Lancet (2000)

930 Citations

N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.

F M Platt;G R Neises;R A Dwek;T D Butters.
Journal of Biological Chemistry (1994)

547 Citations

Targeting glycosylation as a therapeutic approach

Raymond A. Dwek;Terry D. Butters;Frances M. Platt;Nicole Zitzmann.
Nature Reviews Drug Discovery (2002)

525 Citations

Prevention of Lysosomal Storage in Tay-Sachs Mice Treated with N-Butyldeoxynojirimycin

F M Platt;G R Neises;G Reinkensmeier;M J Townsend.
Science (1997)

461 Citations

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents

Nicole Zitzmann;Anand S. Mehta;Sandra Carrouée;Terry D. Butters.
Proceedings of the National Academy of Sciences of the United States of America (1999)

460 Citations

Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase.

Michael A Simpson;Harold Cross;Christos Proukakis;David A Priestman.
Nature Genetics (2004)

409 Citations

Inhibition of Glycosphingolipid Biosynthesis: Application to Lysosomal Storage Disorders

Terry D. Butters;Raymond A. Dwek;Frances M. Platt.
Chemical Reviews (2000)

374 Citations

Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.

Jean Pyo Lee;Mylvaganam Jeyakumar;Rodolfo Gonzalez;Hiroto Takahashi.
Nature Medicine (2007)

333 Citations

Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease.

D. Elstein;C. Hollak;J. M. F. G. Aerts;S. van Weely.
Journal of Inherited Metabolic Disease (2004)

303 Citations

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.

Terry D. Butters;Raymond A. Dwek;Frances M. Platt.
Glycobiology (2005)

298 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Terry D. Butters

Frances M. Platt

Frances M. Platt

University of Oxford

Publications: 110

Johannes M. F. G. Aerts

Johannes M. F. G. Aerts

Leiden University

Publications: 107

George W. J. Fleet

George W. J. Fleet

University of Oxford

Publications: 84

Atsushi Kato

Atsushi Kato

University of Toyama

Publications: 73

Raymond A. Dwek

Raymond A. Dwek

University of Oxford

Publications: 68

Nicole Zitzmann

Nicole Zitzmann

University of Oxford

Publications: 50

Carmen Ortiz Mellet

Carmen Ortiz Mellet

University of Seville

Publications: 45

Rolf G. Boot

Rolf G. Boot

Leiden University

Publications: 45

Herman S. Overkleeft

Herman S. Overkleeft

Leiden University

Publications: 41

Anthony H. Futerman

Anthony H. Futerman

Weizmann Institute of Science

Publications: 40

Max Crispin

Max Crispin

University of Southampton

Publications: 38

Evan Y. Snyder

Evan Y. Snyder

Discovery Institute

Publications: 37

Timothy M. Block

Timothy M. Block

Drexel University

Publications: 36

José M. García Fernández

José M. García Fernández

University of Seville

Publications: 35

Pierre Vogel

Pierre Vogel

École Polytechnique Fédérale de Lausanne

Publications: 35

Konrad Sandhoff

Konrad Sandhoff

University of Bonn

Publications: 33

Trending Scientists

Charles Consel

Charles Consel

Institut Polytechnique de Bordeaux

Scott Mahlke

Scott Mahlke

University of Michigan–Ann Arbor

Georg Schitter

Georg Schitter

TU Wien

Frank Rominger

Frank Rominger

Heidelberg University

Tze-Bin Song

Tze-Bin Song

University of California, Los Angeles

Michael Boutros

Michael Boutros

Heidelberg University

Lin Ma

Lin Ma

Chinese Academy of Sciences

Gilbert Jay

Gilbert Jay

American Red Cross

John R. Murphy

John R. Murphy

Johns Hopkins University

Chris W. Michiels

Chris W. Michiels

KU Leuven

Baiqi Ning

Baiqi Ning

Chinese Academy of Sciences

Marie Bee Hui Yap

Marie Bee Hui Yap

Monash University

Håkan Stattin

Håkan Stattin

Uppsala University

Mathilde Touvier

Mathilde Touvier

Paris 13 University

Gary Maartens

Gary Maartens

University of Cape Town

Veena Das

Veena Das

Johns Hopkins University

Something went wrong. Please try again later.